PositoAI/ US/ SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc.

NasdaqGS: SGP · Healthcare

Positivity Index

#5,363 / 6,775

Global

#2,894 / 4,000

United States

Positivity Score

17,713

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

SpyGlass Pharma, Inc. — Overview & Financial Snapshot

SpyGlass Pharma, Inc. (NasdaqGS: SGP) is a Healthcare company, ranked #5,363 of 6,775 companies globally and #2,894 of 4,000 in United States on PositoAI, with a Positivity Score of 17,713. Its market capitalisation is ₹9,028.94 Cr ($952.60M), P/E ratio is -11.3 and P/B ratio is 4.10. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

P/B Ratio 4.10

P/E Ratio -11.3

D/E Ratio 0.01

ROE —

Owes vs Owns ? 0.05× Low $0.05 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-237.90$-2.51

Forward EPS ₹-266.76$-2.81

Beta —

Market Cap ₹9,028.94 Cr$952.60M

What these numbers mean →

What does SpyGlass Pharma, Inc. do?

What is SpyGlass Pharma, Inc.'s P/E and P/B ratio?

SpyGlass Pharma, Inc. has a P/E ratio of -11.3 and a P/B ratio of 4.10.

What is SpyGlass Pharma, Inc.'s debt-to-equity ratio?

SpyGlass Pharma, Inc. has a debt-to-equity ratio of 0.01.

How much does SpyGlass Pharma, Inc. owe compared with what it owns?

SpyGlass Pharma, Inc. owes $0.05 for every $1 it owns (balance sheet Jun 2026), which is low.

What is SpyGlass Pharma, Inc.'s Positivity rank?

SpyGlass Pharma, Inc. is ranked #5,363 of 6,775 companies globally and #2,894 of 4,000 in United States on PositoAI, with a Positivity Score of 17,713.

Does SpyGlass Pharma, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for SpyGlass Pharma, Inc..

Where can I read the latest news about SpyGlass Pharma, Inc.?

Recent headlines about SpyGlass Pharma, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does SpyGlass Pharma, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of SpyGlass Pharma, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.